OR WAIT 15 SECS
August 10, 2015.
Global pharma sales are to grow to $1.3 trillion by 2018, according to Thomson Reuters. The 2015 CMR Pharmaceutical R&D Factbook identifies a surge in global sales with 2014’s $1 trillion milestone and forecasts sales to reach $1.3 trillion by 2018. It also reveals a positive shift in new molecular entities (NMEs) with 46 launches in 2014; the highest in over a decade.
The study underscores a promising industry outlook with increases in sales and NME launches and with shifting trends in R&D pipeline volume and therapeutic areas as evidenced by these other key findings:
“This is an extraordinary year for pharma,” commented Basil Moftah, president, Thomson Reuters IP & Science. “Not only do the critical insights provided by the Factbook challenge negative perceptions, but it demonstrates this industry’s continued commitment to creating and employing innovative solutions to tackle its largest hurdles.”
For more information see the CMR Factbook.